Skip to main content
Graphic in blue depicting various healthcare items: ambulances, pills, a blue cross and wheelchair

US healthcare after COVID-19: What’s next and how could it be better?

Laura Flanders

Laura Flanders

Host and founder, The Laura Flanders Show more

Health & Wellbeing

In March, the Medicare for All act was reintroduced in the House of Representatives with a record amount of cosponsors. Public support for a single-payer system has never been stronger, and American’s relationship to their healthcare has never been more fraught. Over 500,000 Americans have died of COVID-19, and millions are without coverage. Clearly, we need a change. But what kind of change?

This episode of “The Laura Flanders Show” features health economist and Next System Project director Dana Brown and two outspoken nurses in public hospitals, one in Veterans Affairs, who know intimately the pros and cons of the American healthcare system. We’ve cheered for health care workers in the past year. Now we listen to them about how to make US healthcare better for everyone.

Dana Brown says the US already has a public health care model that works. “My question is: What would our healthcare system look like if it was a system? One advantage that the VA or the British NHS has is that it’s more of a system, and it’s more integrated.”

Brown says we need a shift in how we think about healthcare. “If we think of healthcare as a public utility or a right, rather than a service you can buy, the calculus changes, because of the positive externalities of having a healthy population. … You subsidize it, like you subsidize public transportation, because it has positive benefits for the economy, for local businesses, for people.”

Laura Flanders

Laura Flanders

Host and founder, The Laura Flanders Show more

More related work

Health innovation policy for the people

Health innovation policy for the people

Healthcare innovation policy in the United States has yielded some benefits but has also done harm, specifically when it comes o health equity. This paper identifies four such harms and offers recommendations that address the needs of marginalized communities and produces for all of us the innovations we really need. read more
Medicine Cost

Americans deserve publicly owned generic drugs

Bold policies could have saved America’s largest generic drug plant, but it’s never too late to start putting communities first. read more
Mylan/Viatris plant protest

The US is about to lose its largest generic pharmaceutical plant. It doesn’t have to.

We support a call on the Biden administration to use the Defense Production Act to keep the Viatris Morgantown, West Virginia drug plant open, and to adopt an industrial strategy that prioritizes public health over private greed. read more